News

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...
So far this year, influenza cases are nearly 20 per cent higher than they were last year, and 2,800 cases were recorded in ...
Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...
Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...
The vaccine panel hand-selected by health secretary and anti-vaccine advocate Robert F. Kennedy Jr. on Thursday voted ...
Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...
The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.
Both swine and avian influenza are strains of influenza A. Just as swine flu strains tend to infect pigs, avian flu strains ...
In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...
The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.
Flu cases in Queensland in the past six months now outnumber the total recorded over the same period last year – and doctors ...
While respiratory illnesses such as flu and cough affect Ugandans year-round, researchers have identified specific months ...